ew Drug trial in prevention of the progression of myopia in Indian childre
Phase 4
- Conditions
- Health Condition 1: H521- Myopia
- Registration Number
- CTRI/2021/11/038177
- Lead Sponsor
- Dr Siddharam S Janti
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 )Age of 5 to 16 years
2 ) Myopia â?? 1D to -6 D
3 )Annual myopic progression of greater than 0.5 D
Exclusion Criteria
â??Refractive Myopia
â??Astigmatism >= 1.5 D
â??Amblyopia
â??Prior intraocular surgery
â??Allergy to atropine eye drops
â??Systemic diseases associated with myopia such as Marfan syndrome, Stickler syndrome
â??History of cardiac or significant respiratory diseases
â??Lack of consent for participating in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quantitative assessment of change in refractive error before and after treatment of different concentrations of atropineTimepoint: 3 , 6 and 12 months
- Secondary Outcome Measures
Name Time Method 1)Measurement of axial length before and after treatment of different concentrations of atropine <br/ ><br>2 ) Side effects of low concentration of atropine <br/ ><br>Timepoint: 3 , 6 and 12 months